Melasma

Melasma is a chronic skin condition that manifests as irregular patches of darkened skin, predominantly on the face. Although it can affect anyone, it is more commonly observed in women, particularly during periods of hormonal fluctuation such as pregnancy or when using hormonal contraceptives. The condition is characterised by the appearance of brown or grey-brown patches, typically on the cheeks, forehead, nose, and chin. These patches result from the overproduction of melanin by melanocytes, the cells responsible for pigment in the skin.

The precise causes of melasma are complex and not entirely understood, but several factors are known to contribute to its development. Genetic predisposition plays a significant role, with a higher incidence observed in individuals with a family history of melasma. Additionally, ultraviolet (UV) light exposure is a major trigger because it stimulates melanocytes to produce more melanin. Hence, sun exposure can exacerbate the condition, making sun protection a crucial aspect of managing melasma.

Hormonal influences are also significant, as evidenced by the frequent onset of melasma during pregnancy, referred to as the "mask of pregnancy," or when taking oral contraceptives or hormone replacement therapy. These hormonal changes appear to sensitise melanocytes to UV light, increasing their activity. Furthermore, stress and thyroid disease have been implicated as potential contributors to the condition, suggesting that a variety of physiological and environmental factors can influence melanin production.

Treatment for melasma must be tailored to the individual and often requires a multifaceted approach. Sun protection is foundational, with the consistent use of broad-spectrum sunscreens that protect against both UVA and UVB rays. Sunscreens containing physical blockers like titanium dioxide or zinc oxide are particularly effective as they provide a barrier against UV radiation. Additionally, wearing wide-brimmed hats and seeking shade are advisable to minimise direct sun exposure.

Topical treatments are commonly prescribed to lighten the dark patches. These include ingredients such as hydroquinone, which inhibits melanin production; tretinoin, which accelerates cellular turnover; and corticosteroids, which can help to reduce inflammation. These agents are often used in combination to enhance their efficacy. For instance, a compounded formulation known as a triple cream, which combines hydroquinone, tretinoin, and a corticosteroid, is widely regarded as an effective treatment for melasma.

Chemical peels and laser treatments can also be beneficial for some patients. Chemical peels involve the application of a solution to the skin, which causes the top layers to peel off, potentially lightening areas of hyperpigmentation. Laser treatments, on the other hand, target melanin specifically and can help break down the pigment in the darker areas of the skin. However, these treatments must be approached with caution, as there is a risk of post-inflammatory hyperpigmentation, particularly in individuals with darker skin tones.